These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8992875)
1. Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogs. Monier-Faugere MC; Geng Z; Qi Q; Arnala I; Malluche HH J Bone Miner Res; 1996 Apr; 11(4):446-55. PubMed ID: 8992875 [TBL] [Abstract][Full Text] [Related]
2. A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs. Monier-Faugere MC; Friedler RM; Bauss F; Malluche HH J Bone Miner Res; 1993 Nov; 8(11):1345-55. PubMed ID: 8266826 [TBL] [Abstract][Full Text] [Related]
3. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872 [TBL] [Abstract][Full Text] [Related]
4. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats. Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950 [TBL] [Abstract][Full Text] [Related]
5. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study. Brixen K; Kassem M; Nielsen HK; Loft AG; Flyvbjerg A; Mosekilde L J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366 [TBL] [Abstract][Full Text] [Related]
6. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone. Liu CC; Kalu DN; Salerno E; Echon R; Hollis BW; Ray M J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755 [TBL] [Abstract][Full Text] [Related]
7. Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat. Mitlak BH; Burdette-Miller P; Schoenfeld D; Neer RM J Bone Miner Res; 1996 Apr; 11(4):430-9. PubMed ID: 8992873 [TBL] [Abstract][Full Text] [Related]
8. Osteoporosis by ovariectomy: calcitonin effect in an experimental model on the rat. Gnudi S; Giardino R; Mongiorgi R; Zati A; Giavaresi GL; Bertocchi G; Gandolfi MG; Avella M Boll Soc Ital Biol Sper; 1993 Sep; 69(9):563-70. PubMed ID: 8155314 [TBL] [Abstract][Full Text] [Related]
9. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043 [TBL] [Abstract][Full Text] [Related]
10. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596 [TBL] [Abstract][Full Text] [Related]
12. Sequential histomorphometric changes in cancellous bone from ovariohysterectomized dogs. Boyce RW; Franks AF; Jankowsky ML; Orcutt CM; Piacquadio AM; White JM; Bevan JA J Bone Miner Res; 1990 Sep; 5(9):947-53. PubMed ID: 2281825 [TBL] [Abstract][Full Text] [Related]
13. The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site. Boyce RW; Paddock CL; Gleason JR; Sletsema WK; Eriksen EF J Bone Miner Res; 1995 Feb; 10(2):211-21. PubMed ID: 7754801 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats. Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632 [TBL] [Abstract][Full Text] [Related]
15. Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium. Lindsay R; Zhou H; Cosman F; Nieves J; Dempster DW; Hodsman AB J Bone Miner Res; 2007 Apr; 22(4):495-502. PubMed ID: 17227219 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats. Li M; Shen Y; Burton KW; DeLuca PP; Mehta RC; Baumann BD; Wronski TJ Bone; 1996 Apr; 18(4):375-80. PubMed ID: 8726397 [TBL] [Abstract][Full Text] [Related]
17. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study. Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430 [TBL] [Abstract][Full Text] [Related]
18. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. Liu CC; Kalu DN J Bone Miner Res; 1990 Sep; 5(9):973-82. PubMed ID: 2281827 [TBL] [Abstract][Full Text] [Related]
19. Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation. Kawelke N; Bentmann A; Hackl N; Hager HD; Feick P; Geursen A; Singer MV; Nakchbandi IA J Bone Miner Res; 2008 Aug; 23(8):1278-86. PubMed ID: 18348696 [TBL] [Abstract][Full Text] [Related]
20. Simvastatin increases osteoblasts and osteogenic proteins in ovariectomized rats. Ho ML; Chen YH; Liao HJ; Chen CH; Hung SH; Lee MJ; Fu YC; Wang YH; Wang GJ; Chang JK Eur J Clin Invest; 2009 Apr; 39(4):296-303. PubMed ID: 19292885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]